Wells Fargo’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $621K | Sell |
|
|||||
|
2021
Q4 | $737K | Sell |
|
|||||
|
2021
Q3 | $2.42M | Buy |
|
|||||
|
2021
Q2 | $2.4M | Buy |
|
|||||
|
2021
Q1 | $1.39M | Sell |
|
|||||
|
2020
Q4 | $1.73M | Buy |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $1.09M | Buy |
|
|||||
|
2020
Q1 | $717K | Buy |
|
|||||
|
2019
Q4 | $841K | Buy |
|
|||||
|
2019
Q3 | $282K | Sell |
|
|||||
|
2019
Q2 | $664K | Sell |
|
|||||
|
2019
Q1 | $777K | Buy |
|
|||||
|
2018
Q4 | $644K | Buy |
|
|||||
|
2018
Q3 | $289K | Sell |
|
|||||
|
2018
Q2 | $5.15M | Buy |
|
|||||
|
2018
Q1 | $4.25M | Buy |
|
|||||
|
2017
Q4 | $3.17M | Buy |
|
|||||
|
2017
Q3 | $4.33M | Buy |
|
|||||
|
2017
Q2 | $3.35M | Buy |
|
|||||
|
2017
Q1 | $2.18M | Buy |
|
|||||
|
2016
Q4 | $1.47M | Buy |
|
|||||
|
2016
Q3 | $687K | Buy |
|
|||||
|
2016
Q2 | $369K | Buy |
|
|||||
|
2016
Q1 | $176K | Buy |
|
|||||
|
2015
Q4 | $234K | Sell |
|
|||||
|
2015
Q3 | $355K | Sell |
|
|||||
|
2015
Q2 | $553K | Buy |
|
|||||
|
2015
Q1 | $517K | Buy |
|
|||||
|
2014
Q4 | $396K | Buy |
|
|||||
|
2014
Q3 | $249K | Sell |
|
|||||
|
2014
Q2 | $435K | Buy |
|
|||||
|
2014
Q1 | $530K | Hold |
|
|||||
|
2013
Q4 | $677K | Buy |
|
|||||
|
2013
Q3 | $542K | Buy |
|
|||||
|
2013
Q2 | $547K | Buy |
|